Zelira Therapeutics Limited - Company Profile Report | Alfabank-Adres
mobile menu
business
AU & NZ ENTERPRISE PROFILES

Zelira Therapeutics Limited - Australian Company Profile

Enterprise Type: Public Company

ASX Code: ZLD

What does Zelira Therapeutics Limited do?

Zelira Therapeutics Limited, is a locally-owned, publicly-lised company, that derives its revenue from the provision of branded cannabinoid-based medicines that treat a variety of medical conditions it its prescriptions. The company employs approximately 1-10 employees, operates in Australia and the United States of America, and is administered by its head office in Perth, Western Australia.

Zelira Therapeutics Limited is listed on the Australian Securities Exchange under the code ZLD.

Zelira Therapeutics Limited - Products & Brands

Zelira Therapeutics Limited is an ASX listed pharmaceutical (medicinal cannabis) company, conducting clinical trial research and selling a range of pharmaceutical products.

The research conducted, examines patients with breast, brain and pancreatic cancer as well as diabetes. Patients with autism, insomnia and chronic pain are also examined in the trials.

The company also offers a range of pharmaceutical products used by doctors, pharmacists and patients, operating in Australia and the USA.

The company's main proprietary medications include:

  • ZENIVOL - Cannabinoid drug for the treatment of chronic insomnia.
  • HOPE - Cannabinoid drug for treatment of Autism.
  • RAF FIVE - Acne treatment products.
  • SprinJeneCBD - Oral care products.

 

Alfabank-Adres provides enterprise profiles on thousands of leading organizations across Australia and New Zealand.

LEARN MORE

Zelira Therapeutics Limited - Financial Statements

pie_chart Zelira Therapeutics Limited Financial Profit & Loss Account

BALANCE DATE6/30/20246/30/20236/30/20226/30/20216/30/2020
Sales Revenue00.00.00.00
Other Revenue0000000000000000000000000
Total Revenue0000000000000000000000000
Cost of Goods Sold0000000000000000000000000
Depreciation0000000000000000000000000
R & D Expenditure0000000000000000000000000
lock To view Zelira Therapeutics Limited's full competitive environment, see report purchase options.
Purchase this report or a membership to unlock the full analysis of the capital intensity of this industry.

Zelira Therapeutics Limited - Financial Ratios

pie_chart Zelira Therapeutics Limited Financial Growth

BALANCE DATE6/30/20246/30/20236/30/20226/30/20216/30/2020
Total Revenue Growth-94.39-41.4638.2799.3322.23
Sales Revenue Growth0000000000000000000000000
EBITDA0000000000000000000000000
NPAT0000000000000000000000000
Shareholder's Funds0000000000000000000000000
AAAAAA AAAAAA0000000000000000000000000

pie_chart Zelira Therapeutics Limited Financial Ratios

BALANCE DATE6/30/20246/30/20236/30/20226/30/20216/30/2020
Return on Revenue (ROR) (%)-38693.0-329.0-412.8-408.5-668.1
Return on Shareholders’ Funds (ROSF) (%)0000000000000000000000000
Return on Assets (ROA) (%)0000000000000000000000000
Profit Margin (%)0000000000000000000000000
Revenue per Employee ($’000 per person)0000000000000000000000000
AAAAAA AAAAAA0000000000000000000000000
lock To view Zelira Therapeutics Limited's full competitive environment, see report purchase options.
Purchase this report or a membership to unlock the full analysis of the capital intensity of this industry.

Zelira Therapeutics Limited's Competitive Environment

Zelira Therapeutics Limited operates in the following industries:

Zelira Therapeutics Limited's main competitors:

  • CSL Limited
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
lock To view Zelira Therapeutics Limited's full competitive environment, see report purchase options.
Purchase this report or a membership to unlock the full analysis of the capital intensity of this industry.

Looking for Alfabank-Adres Industry Reports?

Gain strategic insight and analysis on 700+ Australian industries
(& thousands of global industries)

Enterprise Profiles - table of contents

Enterprise Details

Get a high-level overview of Zelira Therapeutics Limited, including registered business details, an enterprise synopsis, SWOT analysis and main brands and products.

Key Personnel

We outline the key personnel at Zelira Therapeutics Limited by position type and title.

Enterprise Financials

Get a full view of Zelira Therapeutics Limited’s financials, including Profit and Loss Account (Revenue, Interest, Profit and Loss, and Audit Fees) and Balance Sheet (Current Assets, Non-Current Assets, Current Liabilities, Non-Current Liabilities, Shareholders’ Equity), as well as Number of Employees, Number of Share on Issue, Market Capitalisation and Earnings per Share where available. Note: we do not provide a full financial details for all company profiles.

Growth & Ratios

Get a clearer picture of Zelira Therapeutics Limited’s performance, with key financial ratios and data on financial growth.

Operating Segments

Understand the main operating divisions of Zelira Therapeutics Limited, including Revenue and Assets under each Segment, Industries and Geographic Locations Zelira Therapeutics Limited operates in.

Competitor Benchmarking

Compare Zelira Therapeutics Limited’s financial ratios and growth to peers in their industries of operation for a clearer picture of performance.

Major Shareholders

We outline the ultimate parent and largest shareholders of Zelira Therapeutics Limited.

Subsidiaries

View a list of Zelira Therapeutics Limited’s associated companies, holding company, joint ventures and trusts, both domestic and international.

History

Find out more about the history and background of Zelira Therapeutics Limited, including founding information, past announcements, mergers and major projects.

Purchase to Read Full Report

100% Money Back Guarantee Digicert Trusted

Included in Report

  • Enterprise History & Synopsis
    Enterprise History & Synopsis
  • Enterprise Financial Statements
    Enterprise Financial Statements
  • Financial Ratios
    Financial Ratios
  • Industry Averages
    Industry Averages
  • Competitive Landscape
    Competitive Landscape
  • Key Enterprise Personnel
    Key Enterprise Personnel
  • Subsidiaries & Ownership Structure
    Subsidiaries & Ownership Structure

Why buy this enterprise profile on Zelira Therapeutics Limited?

Alfabank-Adres enterprise profiles enable you to:

  • Understand a enterprise’s competitive landscape
  • Identify industry trends a enterprise is exposed to
  • Inform your decisions for marketing, strategy and planning
  • Target key enterprise personnel

The profile on Zelira Therapeutics Limited includes:

  • Enterprise History and Synopsis
  • Overview of Brands and Products
  • Enterprise Financial Statements and Financial Ratios
  • Key Enterprise Personnel
  • Subsidiaries, Shareholders and Ownership Structure
  • Service Providers

Alfabank-Adres provides profiles on thousands of leading enterprises across Australia and New Zealand, as well as reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends. Our expert reports are thoroughly researched, reliable and current, enabling you to make faster, better business decisions.

Trusted by More Than 10,000 Clients Around the World

  • Alfabank-Adres client - VISA
  • Alfabank-Adres client - ADP
  • Alfabank-Adres client - Deloitte
  • Alfabank-Adres client - AMEX
  • Alfabank-Adres client - Bank of Montreal